Victory Capital Management
PRNB

Victory Capital Management’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Victory Capital Management’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-10,606
Closed -$634K – 2597
2020
Q2 		$634K Buy
10,606
+3,147
+42% +$194K ﹤0.01% 1907
2020
Q1 		$443K Sell
7,459
-23,738
-76% -$1.38M ﹤0.01% 1887
2019
Q4 		$1.71M Buy
31,197
+3,162
+11% +$118K ﹤0.01% 1568
2019
Q3 		$792K Buy
28,035
+26,571
+1,815% +$975K ﹤0.01% 1748
2019
Q2 		$49K Hold
1,464
– – ﹤0.01% 1736
2019
Q1 		$50K Sell
1,464
-1,453
-50% -$46.2K ﹤0.01% 1711
2018
Q4 		$80K Sell
2,917
-5,083
-64% -$131K ﹤0.01% 1660
2018
Q3 		$234K Buy
+8,000
New +$226K ﹤0.01% 1566

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Victory Capital Management's PRNB Position: Q3 2020 in Review

Victory Capital Management sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 10,606 shares — an estimated $634K sold.

Victory Capital Management first reported a position in PRNB in Q3 2018 and held it in 8 quarters. The position peaked at $1.71M in Q4 2019. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • Victory Capital Management reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Victory Capital Management sold 10,606 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $634K.
  • Victory Capital Management first reported a position in Principia Biopharma Inc. Common Stock in Q3 2018 and held it in 8 quarters.
  • Victory Capital Management's Principia Biopharma Inc. Common Stock position peaked at $1.71M in Q4 2019.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Victory Capital Management's 13F filing for Q3 2020, filed 9 Nov 2020.